LISATA THERAPEUTICS, INC. Business Combination, Contingent Consideration, Liability
LISATA THERAPEUTICS, INC. (LSTA) had Business Combination, Contingent Consideration, Liability of $0 as of 2015-12-31, per its 10-K filed 2016-03-15.
Discontinued › Balance Sheet › Liabilities
us-gaap:BusinessCombinationContingentConsiderationLiability · last filed 2016-03-15
- 2015-12-31: Business Combination, Contingent Consideration, Liability $0.00.
- 2015-09-30: Business Combination, Contingent Consideration, Liability $13.88M.
- 2015-06-30: Business Combination, Contingent Consideration, Liability $13.46M.
- 2015-03-31: Business Combination, Contingent Consideration, Liability $18.81M.
| Period end | Business Combination, Contingent Consideration, Liability | Business Combination, Contingent Consideration, Liability as first filed |
|---|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-03-15 | |
| 2015-09-30 | $13.88M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $13.46M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $18.81M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $18.26M 10-K · filed 2016-03-15 | |
| 2014-09-30 | $22.43M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $20.64M 10-Q · filed 2014-08-07 | |
| 2014-05-08 | $11.90M 10-K · filed 2016-03-15 | $10.80M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $9.64M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $9.45M 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |